Heart Failure Clinical Trial
Official title:
Selective Coronary Vein Sampling in Dyssynchronous Heart Failure and Cardiac Resynchronisation Therapy to Assess Physiological Response to Exercise and Characterise Regional Release of Novel Biomarkers
Cardiac resynchronisation therapy (CRT) prolongs the life and improves the symptoms in patients with heart failure and electrical dyssynchrony. 30-50% of patients do not improve with the treatment which is both expensive and not without complication. Despite much research, we cannot accurately predict who will not respond. Furthermore, most heart failure patients gets symptoms on exercise and most studies have examined patients at rest. We propose to investigate the effect of exercise on different parts of the left ventricle by sampling various biomarkers of metabolism, myocardial injury and gene expression. We will then repeat the protocol following device insertion to look for changes. This novel work will require a small cohort of patients with heart failure and no electrical dyssynchrony and normal patients to act as controls. We will also measure novel biomarkers at different venous sites relating to different parts of the myocardium to determine whether they can be used to prognosticate or even predict response to CRT.
We propose to examine the acute effects of exercise on patients with dyssynchronous
electrical activation of the heart and heart failure and to compare the release of novel
biomarkers in selective areas of coronary venous drainage by direct cannulation of different
veins via the coronary sinus (CS).
The study design will separate patients into a minimally invasive arm (MINARM)and an
invasive arm (INARM). The INARM will be recruited from patients in the MINARM.
MINARM
Group 1: 40 patients scheduled for CRT implant Group 2: 15 patients with heart failure and
no dyssynchrony Group 3: 15 patients with normal hearts
Group 1:
40 patient undergoing CRT will have venous samples taken from the CS, two CS tributaries,
peripheral venous and peripheral arterial sites at the time of CRT insertion at the time of
device implant. Blood samples will be analysed for metabolites and novel biomarkers
They will then undergo repeat sampling at 6 months to assess for changes in the micro RNA
and biomarker profile including CS sampling.
Group 2 and 3
A control arm of 15 patients with heart failure and no dyssynchrony (Group 2) and 15
patients with normal hearts (Group 3) will undergo peripheral venous sampling for biomarkers
and this will be repeated at 6 months. These samples will allow for control against the
dyssynchronous heart failure group and also for temporal changes in micro RNA expression.
10 patient from Group 1 and 5 from Group 2 and 3 will be invited to from part of the INARM
at the time of recruitment.
INARM study
Methods:
GROUP A 10 pts with heart failure and dyssynchronous ventricular contraction GROUP B 5 pts
with heart failure and no electrical dyssynchrony schedule for either coronary angiography
or electrophysiology study.
GROUP C 5 pts schedule for diagnostic coronary angiography or electrophysiology study with
normal cardiac function
The exact details of the protocol will vary depending upon the Group:
GROUP A
1 On the day preceding the CRT implant will attend hospital for a temporary invasive
catheter study. A pacing protocol will be performed using a pacing wire inserted into the
right atrium. Coronary sinus venous blood sampling will be performed using a catheter placed
via the femoral or internal jugular vein. At the chief investigator's discretion a specially
designed exercise bicycle that allow supine exercise in the catheter lab will be used rather
than the atrial pacing wire.
3 6 months post implant the patients will return to the catheter laboratory for a further
study. This will repeat the protocol but with the device having been on for 6 months. This
will require further arterial access as described above. This study should take
approximately an hour.
GROUP B and C
It is common practice for these patients to have a coronary angiogram to exclude ischaemic
heart disease as the cause of their heart failure or chest pain or to have electrophysiology
study to determine the mechanism of arrhythmia. If their angiogram is normal,we will perform
a pacing protocol (this will be required if they are attending for an electrophysiology
study). This will require 2 femoral venous access sites (similar to standard
electrophysiological study) to allow temporary atrial pacing and acquisition of blood
samples from the coronary sinus. Following the invasive part of the study patients in Group
B and C will fall back into Group 2 and 3 of MINARM and attend at 6 month for peripheral
blood sampling.
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|